|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/19 | |
| A61K 31/69 | |||
| A61K 33/22 | |||
| A61K 9/00 |
| (11) | Number of the document | 2624818 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11770615.0 |
| Date of filing the European patent application | 2011-10-04 | |
| (97) | Date of publication of the European application | 2013-08-14 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/054703 |
| Date | 2011-10-04 |
| (87) | Number | WO 2012/047845 |
| Date | 2012-04-12 |
| (30) | Number | Date | Country code |
| 390046 P | 2010-10-05 | US |
| (72) |
USAYAPANT, Arunya, US
BOWMAN, David, US
|
| (73) |
Fresenius Kabi USA, LLC,
1501 E. Woodfield Road, Suite 300E, Schaumburg, IL 60173,
US
|
| (54) | BORTEZOMIB FORMULATIONS STABILISED WITH BORIC ACID |
| BORTEZOMIB FORMULATIONS STABILISED WITH BORIC ACID |